is a topic covered in the Johns Hopkins ABX Guide
To view the entire topic, please sign in or purchase a subscription.
Pediatrics Central™ is an all-in-one application that puts valuable medical information, via your mobile device or the web, in the hands of clinicians treating infants, children, and adolescents. Explore these free sample topics:
-- The first section of this topic is shown below --
Triclabendazole is not currently FDA approved for use in the United States.
- Available through the CDC under an investigational drug protocol
- Triclabendazole is included on the WHO Essential Drug List for the management of fascioliasis.
-- To view the remaining sections of this topic, please sign in or purchase a subscription --
Last updated: October 25, 2016
TY - ELEC
T1 - Triclabendazole
ID - 540674
A1 - Dzintars,Kathryn,PharmD, BCPS
Y1 - 2016/10/25/
BT - Johns Hopkins ABX Guide
UR - https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540674/all/Triclabendazole
PB - The Johns Hopkins University
DB - Pediatrics Central
DP - Unbound Medicine